C.DIFF BREAKTHROUGH: Genetic Lab to Share Gut Microbiome Discovery at ACG 2019

MALIBU, Calif., Oct. 28, 2019 /PRNewswire/ -- Progenabiome, a physician-owned genetic sequencing laboratory, found cutting-edge data on Clostridium difficile (C.diff), a disease burdening 500,000+ Americans yearly. They will present a validated, verified, and reproduced C.diff Assay at The American College of Gastroenterology (ACG) 2019 Annual ...